Gujarat Themis Biosyn (GUJTHEM) Share Price falls 5.29% as Mid Cap pharma stock trades lower
- September 9, 2026
- Posted by: Kunal Singla
- Category: News
Gujarat Themis Biosyn Share Price was at Rs 371.3, down 5.29% from the previous close of Rs 392.05, while market capitalisation stood at Rs 5,102.6 Cr. The move came after the stock opened at Rs 387.1 and touched an intraday high of Rs 387.1 before sliding to the day’s low of Rs 371.3. Univest figures confirm the price action, but they do not point to a specific company trigger. For readers following Gujarat Themis Biosyn Share Price Today, the decline places today’s price action, valuation and healthcare-sector comparison in the spotlight. The stock is also a Mid Cap, which gives the move a different context from smaller listed names in the same industry. Gujarat Themis Biosyn Share Price news therefore centres on the numbers that are visible now: the fall, the range and the company’s fundamental profile.
Gujarat Themis Biosyn (GUJTHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 371.3 |
| Previous Close | Rs 392.05 |
| Today's Move | -Rs 20.75 (-5.29%) |
| Open | Rs 387.1 |
| High | Rs 387.1 |
| Low | Rs 371.3 |
| Market Capitalisation | Rs 5,102.6 crore |
| Market Cap Category | Mid Cap |
Gujarat Themis Biosyn Share Price Today showed a clear downside move from the opening level. The stock opened at Rs 387.1, matched the day’s high at Rs 387.1, and then eased to Rs 371.3, which was also the low for the market phase covered here. The previous close was Rs 392.05, so the day change was Rs -20.75 and the percentage move was -5.29%. That means Gujarat Themis Biosyn Share Price spent the entire recorded range below the prior close, with no rebound back to the opening level. In market-cap terms, the company stood at Rs 5,102.6 Cr and falls in the Mid Cap category. For anyone scanning Gujarat Themis Biosyn Share Price Live or Gujarat Themis Biosyn Share Price Update, this is a straightforward price fall day rather than a broad narrative shift. The next lens is fundamental analysis.
Gujarat Themis Biosyn (GUJTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,102.6 crore |
| P/E Ratio | 104.8x |
| P/B Ratio | 4.87x |
| ROE | 17.41% |
| ROCE | 18.16% |
| EPS | Rs 3.74 |
| Book Value Per Share | Rs 80.59 |
| Dividend Yield | 0.17% |
Gujarat Themis Biosyn (GUJTHEM) fundamental metrics show P/E 104.8x, P/B 4.87x, ROE 17.41%, ROCE 18.16%. Taken on their own, these numbers offer context rather than a trading signal.
Gujarat Themis Biosyn has a market capitalisation of Rs 5,102.60 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 104.8x, P/B at 4.87x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 17.41% and ROCE of 18.16%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.74, book value per share of Rs 80.59, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.61%, median ROCE of 13.46%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 104.8x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 46.92x |
| Benchmark P/E Range | 3.13x to 654.72x |
| Company P/B Ratio | 4.87x |
| Benchmark Median P/B | 2.84x |
| Benchmark Average P/B | 4.25x |
| Company ROE | 17.41% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.43% |
| Company ROCE | 18.16% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.3% |
| Company Market Capitalisation | Rs 5,102.6 crore |
| Benchmark Median Market Cap | Rs 827.89 crore |
| Benchmark Average Market Cap | Rs 13,758.85 crore |
Gujarat Themis Biosyn (GUJTHEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Gujarat Themis Biosyn (GUJTHEM) has a P/E ratio of 104.8x, which is above the benchmark median of 31.35x, a difference of +234.29%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Gujarat Themis Biosyn (GUJTHEM) has a ROE of 17.41%, which is above the benchmark median of 11.61%, a difference of +49.96%. Gujarat Themis Biosyn (GUJTHEM) has a ROCE of 18.16%, which is above the benchmark median of 13.46%, a difference of +34.92%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,24,466.35 | 34.69 | 4.85 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,46,222.11 | 81.95 | 13.57 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,76,300.5 | 80.12 | 19.47 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,12,817.68 | 24.84 | 4.16 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,10,823.44 | 100.61 | 19.51 | 18.31 | 18.2 |
Gujarat Themis Biosyn (GUJTHEM) has a P/E ratio of 104.8x compared with the displayed peer median of 80.12x. The comparison is relative and should not be read as a recommendation. Its ROE of 17.41% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 18.16% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gujarat Themis Biosyn (GUJTHEM) has a market capitalisation of Rs 5,102.6 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Gujarat Themis Biosyn
- Gujarat Themis Biosyn Share Price fell 5.29% to Rs 371.3 from Rs 392.05, making today’s move the first point of attention.
- The company remains a Mid Cap with Rs 5,102.6 Cr market capitalisation, which helps frame Gujarat Themis Biosyn Share Price within its size bracket.
- P/E of 104.8 and P/B of 4.87 place Gujarat Themis Biosyn Share Price above the industry median on valuation.
- ROE of 17.41% and ROCE of 18.16% give Gujarat Themis Biosyn Share Price a return profile that is stronger than the industry median.
- Revenue of Rs 423.2 Cr in FY25, EPS of Rs 3.74 and book value of Rs 80.59 are the main fundamentals to watch in Gujarat Themis Biosyn Share Price analysis.
About Gujarat Themis Biosyn
Gujarat Themis Biosyn operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company’s current profile, as reflected in Gujarat Themis Biosyn Share Price, is anchored in a business that is tracked through revenue, profitability ratios and valuation metrics rather than broad market commentary. The company reported revenue of Rs 423.2 Cr for FY25, with EPS of Rs 3.74 and book value of Rs 80.59. Dividend yield is 0.17%, while ROE and ROCE stand at 17.41% and 18.16% respectively. For readers following Gujarat Themis Biosyn Share Price news, the business remains a listed pharma name with measurable return ratios and a meaningful market cap.
Track Gujarat Themis Biosyn Share Price on Univest
Use Gujarat Themis Biosyn (GUJTHEM) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Gujarat Themis Biosyn Share Price on Univest for live updates, fundamental ratios, 52-week levels and market insights. The same page also helps you compare Gujarat Themis Biosyn Share Price with sector peers, valuation metrics and recent company updates in one place. For investors monitoring Gujarat Themis Biosyn Share Price today, Univest keeps the price view and the financial context together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Gujarat Themis Biosyn Share Price falling today?
Ans. Gujarat Themis Biosyn Share Price was down 5.29% to Rs 371.3 from Rs 392.05. Univest figures confirm the price action, but they do not point to a specific company trigger. The intraday range extended from Rs 371.3 to Rs 387.1.
What is Gujarat Themis Biosyn Share Price today?
Ans. Gujarat Themis Biosyn Share Price was at Rs 371.3 in the latest update. The stock moved between Rs 371.3 and Rs 387.1 during the recorded market phase and remained below the previous close.
What does Gujarat Themis Biosyn Share Price today show about the move?
Ans. Gujarat Themis Biosyn Share Price shows a single-day decline of Rs 20.75, or 5.29%. The opening level was Rs 387.1, while the previous close stood at Rs 392.05. The intraday range extended from Rs 371.3 to Rs 387.1.
Is Gujarat Themis Biosyn Share Price expensive compared with peers?
Ans. Gujarat Themis Biosyn Share Price trades at a P/E of 104.8 and a P/B of 4.87. Those multiples sit above the industry median, so the valuation looks richer than many healthcare peers.
What are the main fundamentals behind Gujarat Themis Biosyn Share Price?
Ans. Gujarat Themis Biosyn Share Price is backed by ROE of 17.41%, ROCE of 18.16%, EPS of Rs 3.74 and book value of Rs 80.59. Dividend yield is 0.17%, and leverage is very low.
How does Gujarat Themis Biosyn Share Price compare with the sector benchmark?
Ans. Gujarat Themis Biosyn Share Price has a higher P/E than the healthcare benchmark median and average, but its ROE and ROCE are also above benchmark levels. That gives the stock a premium valuation and stronger return profile.
What is the market capitalisation of Gujarat Themis Biosyn Share Price?
Ans. Gujarat Themis Biosyn Share Price corresponds to a market capitalisation of Rs 5,102.6 Cr. The company sits in the Mid Cap category and is larger than the industry benchmark median market cap.
What revenue is linked to Gujarat Themis Biosyn Share Price?
Ans. Gujarat Themis Biosyn Share Price aligns with FY25 revenue of Rs 423.2 Cr. That revenue figure gives useful context when viewed alongside EPS of Rs 3.74 and a P/E of 104.8.
Should investors track Gujarat Themis Biosyn Share Price on Univest?
Ans. Yes, Gujarat Themis Biosyn Share Price can be tracked on Univest for live price updates, ratios, 52-week levels and market insights. It is useful for following valuation, sector context and daily price action.
